bioAffinity Technologies, Inc. (BIAFW)San Antonio, United States | NasdaqCM
0.30 USD
|
Hot Take ↕ | Oct. 10, 2026, 5:33 a.m. EDT
The security is trading at a historic low where the fifty-two week high and low are identical, indicating a complete lack of liquidity and price discovery. Fundamentally, the company is generating significant negative free cash flow and operating losses, with a negative return on equity that suggests severe capital inefficiency. While the headline mentions record revenue, the underlying financials show deep losses and a massive gap between book value and market price, signaling a potential value trap rather than a bargain. With no dividend history and a beta suggesting extreme volatility relative to the market, there is no safe entry point for either short-term speculation or long-term holding. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 38.076 |
| Revenue per Share | 23.198 |
| Beta | -1.25 |
| Profit Margins | -257.33% |
| Website | https://bioaffinitytech.com |
| Attribute | Value |
|---|---|
| Address1 | 3,300 Nacogdoches Road |
| Address2 | Suite 216 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -1.254 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 8.339 |
| City | San Antonio |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3011 |
| Current Ratio | 1.442 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.42 |
| Day Low | 0.301 |
| Debt To Equity | 38.076 |
| Ebitda | -11,968,556 |
| Ebitda Margins | -2.02823 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.42 |
| Fifty Two Week High Change | -0.1189 |
| Fifty Two Week High Change Percent | -0.28309524 |
| Fifty Two Week Low | 0.301 |
| Fifty Two Week Low Change | 0.00009998679 |
| Fifty Two Week Low Change Percent | 0.00033218204 |
| Fifty Two Week Range | 0.301 - 0.42 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 536,748 |
| Free Cashflow | -6,909,285 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 57 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.3011 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.34607 |
| Gross Profits | 2,042,175 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-06-28 |
| Language | en-US |
| Long Business Summary | bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas. |
| Long Name | bioAffinity Technologies, Inc. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_423045573 |
| Net Income To Common | -15,185,242 |
| Open | 0.47 |
| Operating Cashflow | -11,468,205 |
| Operating Margins | -2.20767 |
| Phone | 210 698 5334 |
| Previous Close | 0.3011 |
| Price Hint | 4 |
| Price To Book | 0.036107447 |
| Profit Margins | -2.5733402 |
| Quick Ratio | 1.24 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.42 |
| Regular Market Day Low | 0.301 |
| Regular Market Day Range | 0.301 - 0.42 |
| Regular Market Open | 0.47 |
| Regular Market Previous Close | 0.3011 |
| Regular Market Price | 0.3011 |
| Regular Market Time | 1,791,990,853 |
| Regular Market Volume | 546 |
| Return On Assets | -1.25114 |
| Return On Equity | -18.60152 |
| Revenue Growth | 0.19 |
| Revenue Per Share | 23.198 |
| Sand P52 Week Change | 0.16207206 |
| Sector | |
| Sector Key | |
| Short Name | bioAffinity Technologies, Inc. |
| Source Interval | 15 |
| State | TX |
| Symbol | BIAFW |
| Total Cash | 2,429,719 |
| Total Cash Per Share | 4.501 |
| Total Debt | 1,435,005 |
| Total Revenue | 5,900,985 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 546 |
| Website | https://bioaffinitytech.com |
| Zip | 78,217 |